SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-18-004157
Filing Date
2018-10-19
Accepted
2018-10-19 15:58:54
Documents
5
Period of Report
2018-10-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 6253
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 8423
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 7007
4 GRAPHIC fb.jpg GRAPHIC 1070
5 GRAPHIC tw.jpg GRAPHIC 1113
  Complete submission text file 0001062993-18-004157.txt   26174
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 181130471
SIC: 1000 Metal Mining